These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9123372)

  • 1. Differential immunodominance of individual MHC locus products: implications for the induction of immunologic tolerance to allografts.
    Saitovitch D; Roelen D; Morris PJ; Wood KJ
    Transplant Proc; 1997; 29(1-2):1443. PubMed ID: 9123372
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo.
    Bell Y; Shoskes D; Morris P; Wood K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):359. PubMed ID: 8438334
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.
    Madsen JC; Superina RA; Wood KJ; Morris PJ
    Nature; 1988 Mar; 332(6160):161-4. PubMed ID: 3279318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone grafting in inbred mice: evidence for H-2K, H-2D, and non-H-2 antigens in bone.
    Halloran PF; Lee E; Ziv I; Langer F
    Transplant Proc; 1979 Jun; 11(2):1507-9. PubMed ID: 382551
    [No Abstract]   [Full Text] [Related]  

  • 5. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
    Young KJ; DuTemple B; Phillips MJ; Zhang L
    J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of non-major histocompatibility complex antigens in the rejection of transplanted myoblasts.
    Boulanger A; Asselin I; Roy R; Tremblay JP
    Transplantation; 1997 Mar; 63(6):893-9. PubMed ID: 9089231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts.
    He G; Kim OS; Thistlethwaite JR; Hart J; Siegel CT; Szot GL; Newell KA
    Transplant Proc; 1999; 31(1-2):1239-41. PubMed ID: 10083553
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic regulation of the antibody response to H-2Db alloantigens in mice. V. Control by several genes of the H-2 complex in mice of the C57BL/10 background.
    Wernet D
    Immunogenetics; 1982; 16(1):71-81. PubMed ID: 6214508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.
    He G; Hart J; Thistlethwaite JR; Newell KA
    Transplant Proc; 1998 Sep; 30(6):2592-3. PubMed ID: 9745505
    [No Abstract]   [Full Text] [Related]  

  • 12. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression.
    Saitovitch D; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):119-20. PubMed ID: 7878844
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal induction of tolerance to cardiac allografts.
    West LJ; Morris PJ; Wood KJ
    Transplant Proc; 1994 Feb; 26(1):207-8. PubMed ID: 8108945
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.
    Mori S; El-Baki H; Mullen CA
    Bone Marrow Transplant; 2003 May; 31(10):865-75. PubMed ID: 12748663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetic control of metastatic competence of cloned tumor cell populations.
    Eisenbach L; De Baetselier P; Katzav S; Segal S; Feldman M
    Symp Fundam Cancer Res; 1983; 36():101-21. PubMed ID: 6332357
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts.
    Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of RT1.C-encoded MHC antigens on host-versus-graft and graft versus-host reactions in a model of small bowel transplantation in the rat.
    Fändrich F; Zhu X; Dresske B; Papachrysanthou A; Exner B; Chambers WH
    Transplant Proc; 1997 May; 29(3):1730-1. PubMed ID: 9142251
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of xenoantigenicity of HLA class I molecules by a complete series of human-mouse hybrid genes.
    Tanabe M; Takiguchi M; Yamamoto J; Hayashi H; Kano K
    Transplantation; 1989 Jul; 48(1):135-40. PubMed ID: 2787554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of anti-self-h-2 antibodies by C3D2F1 mice hyperimmune to L cell/L1210 hybrids and L1210 leukemia cells.
    Kawashima K; Watanabe E; Isobe K; Ogura M; Nagura E; Yamada K; Sobue I; Mizoguchi K; Ito Y; Nagai Y; Nakashima I
    Cell Immunol; 1982 Mar; 67(2):279-86. PubMed ID: 7083334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.